[Federal Register Volume 64, Number 201 (Tuesday, October 19, 1999)]
[Notices]
[Page 56355]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-27171]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meeting: Chronic Fatigue Syndrome Coordinating Committee

    In accordance with section 10(a) of the Federal Advisory Committee 
Act, as amended (5 U.S.C., Appendix 2), the National Institute of 
Allergy and Infectious Diseases (NIAID), National Institutes of Health 
(NIH) announces the following committee meeting.

    Name: Chronic Fatigue Syndrome Coordinating Committee (CFSCC).
    Time and Date: Tuesday, November 2, 1999, 9:00 a.m.-5 p.m.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW, Washington, DC.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card will need to provide a photo ID and 
must know the subject and room number of the meeting in order to be 
admitted into the building. Visitors must use the Independence 
Avenue entrance.
    Purpose: The Commission is charged with providing advice to the 
Secretary, the Assistant Secretary for Health, and the Commissioner, 
Social Security Administration (SSA), to assure interagency 
coordination and communication regarding chronic fatigue syndrome 
(CFS) research and other related issues; facilitating increased 
Department of Health and Human Services (HHS) and agency awareness 
of CFS research and educational needs; developing complementary 
research programs that minimize overlap; identifying opportunities 
for collaborative and/or coordinated efforts in research and 
education; and developing informed responses to constituency groups 
regarding HHS and SSA efforts and progress.
    Matters to be Discussed: Agency updates and a report on CDC's 
CFS Program. Agenda items are subject to change as priorities 
dictate.
    Public Comments will be received at the meeting for a total of 
not more than 60 minutes. Persons wishing to make oral comments 
either in person or via a videotape should notify the contact person 
listed below no later than close of business on October 22, 1999. 
Individuals who have not previously provided testimony will be given 
preference. In the event that there are more requests than can be 
accommodated in the time available, a lottery system will be 
utilized to select speakers. Those selected will be notified on 
October 22, or soon thereafter.
    If a selected individual is unable to deliver their testimony at 
the meeting or submit their video prior to the meeting, their 
testimony slot will be filed on a first come first served basis on 
the day of the meeting following an announcement soliciting 
substitutes by the Chair. Preference of those not previously 
providing testimony will apply. All testimony presented to the 
Committee on the day of the meeting will become part of the public 
record. Public comments will be limited to five minutes per person, 
whether on videotape or in person at the meeting. Copies of any 
written comments should be available for distribution to those 
attending the meeting; speakers should come with at least 50 copies.
    Contact Person for More Information: Louise Garnett, Program 
Coordinator, Division of Microbiology and Infectious Diseases, 
NIAID, NIH, 6700B Rockledge Drive, Room 3266, Bethesda, MD 20892, 
telephone 301-496-1884, fax 301-480-4528.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS.)

    Dated: October 12, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-27171 Filed 10-18-99; 8:45 am]
BILLING CODE 4140-01-M